BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 26279073)

  • 1. Chromium Supplementation and the Effects on Metabolic Status in Women with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial.
    Jamilian M; Asemi Z
    Ann Nutr Metab; 2015; 67(1):42-8. PubMed ID: 26279073
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of zinc supplementation on markers of insulin resistance and lipid profiles in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial.
    Foroozanfard F; Jamilian M; Jafari Z; Khassaf A; Hosseini A; Khorammian H; Asemi Z
    Exp Clin Endocrinol Diabetes; 2015 Apr; 123(4):215-20. PubMed ID: 25868059
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calcium plus vitamin D supplementation affects glucose metabolism and lipid concentrations in overweight and obese vitamin D deficient women with polycystic ovary syndrome.
    Asemi Z; Foroozanfard F; Hashemi T; Bahmani F; Jamilian M; Esmaillzadeh A
    Clin Nutr; 2015 Aug; 34(4):586-92. PubMed ID: 25300649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic response to selenium supplementation in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial.
    Jamilian M; Razavi M; Fakhrie Kashan Z; Ghandi Y; Bagherian T; Asemi Z
    Clin Endocrinol (Oxf); 2015 Jun; 82(6):885-91. PubMed ID: 25510442
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Effects of Synbiotic Supplementation on Metabolic Status in Women With Polycystic Ovary Syndrome: a Randomized Double-Blind Clinical Trial.
    Samimi M; Dadkhah A; Haddad Kashani H; Tajabadi-Ebrahimi M; Seyed Hosseini E; Asemi Z
    Probiotics Antimicrob Proteins; 2019 Dec; 11(4):1355-1361. PubMed ID: 29532416
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Effect of Magnesium and Vitamin E Co-Supplementation on Glycemic Control and Markers of Cardio-Metabolic Risk in Women with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial.
    Jamilian M; Sabzevar NK; Asemi Z
    Horm Metab Res; 2019 Feb; 51(2):100-105. PubMed ID: 30286483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Probiotic supplementation and the effects on weight loss, glycaemia and lipid profiles in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial.
    Ahmadi S; Jamilian M; Karamali M; Tajabadi-Ebrahimi M; Jafari P; Taghizadeh M; Memarzadeh MR; Asemi Z
    Hum Fertil (Camb); 2017 Dec; 20(4):254-261. PubMed ID: 28142296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of melatonin administration on mental health parameters, metabolic and genetic profiles in women with polycystic ovary syndrome: A randomized, double-blind, placebo-controlled trial.
    Shabani A; Foroozanfard F; Kavossian E; Aghadavod E; Ostadmohammadi V; Reiter RJ; Eftekhar T; Asemi Z
    J Affect Disord; 2019 May; 250():51-56. PubMed ID: 30831541
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Effects of Flaxseed Oil Omega-3 Fatty Acids Supplementation on Metabolic Status of Patients with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial.
    Mirmasoumi G; Fazilati M; Foroozanfard F; Vahedpoor Z; Mahmoodi S; Taghizadeh M; Esfeh NK; Mohseni M; Karbassizadeh H; Asemi Z
    Exp Clin Endocrinol Diabetes; 2018 Apr; 126(4):222-228. PubMed ID: 29117618
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Influences of Chromium Supplementation on Glycemic Control, Markers of Cardio-Metabolic Risk, and Oxidative Stress in Infertile Polycystic ovary Syndrome Women Candidate for In vitro Fertilization: a Randomized, Double-Blind, Placebo-Controlled Trial.
    Jamilian M; Zadeh Modarres S; Amiri Siavashani M; Karimi M; Mafi A; Ostadmohammadi V; Asemi Z
    Biol Trace Elem Res; 2018 Sep; 185(1):48-55. PubMed ID: 29307112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of coenzyme Q10 supplementation on glucose metabolism and lipid profiles in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial.
    Samimi M; Zarezade Mehrizi M; Foroozanfard F; Akbari H; Jamilian M; Ahmadi S; Asemi Z
    Clin Endocrinol (Oxf); 2017 Apr; 86(4):560-566. PubMed ID: 27911471
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Trial on The Effects of Magnesium-Zinc-Calcium-Vitamin D Co-Supplementation on Glycemic Control and Markers of Cardio-Metabolic Risk in Women with Polycystic Ovary Syndrome.
    Jamilian M; Maktabi M; Asemi Z
    Arch Iran Med; 2017 Oct; 20(10):640-645. PubMed ID: 29137465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of Chromium and Carnitine Co-supplementation on Body Weight and Metabolic Profiles in Overweight and Obese Women with Polycystic Ovary Syndrome: a Randomized, Double-Blind, Placebo-Controlled Trial.
    Jamilian M; Foroozanfard F; Kavossian E; Kia M; Aghadavod E; Amirani E; Asemi Z
    Biol Trace Elem Res; 2020 Feb; 193(2):334-341. PubMed ID: 30977089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of vitamin D and evening primrose oil co-supplementation on lipid profiles and biomarkers of oxidative stress in vitamin D-deficient women with polycystic ovary syndrome: A randomized, double-blind, placebo-controlled trial.
    Nasri K; Akrami S; Rahimi M; Taghizadeh M; Behfar M; Mazandaranian MR; Kheiry A; Memarzadeh MR; Asemi Z
    Endocr Res; 2018 Feb; 43(1):1-10. PubMed ID: 28742409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Effects of Supplementation with Chromium on Insulin Resistance Indices in Women with Polycystic Ovarian Syndrome: A Systematic Review and Meta-Analysis of Randomized Clinical Trials.
    Heshmati J; Omani-Samani R; Vesali S; Maroufizadeh S; Rezaeinejad M; Razavi M; Sepidarkish M
    Horm Metab Res; 2018 Mar; 50(3):193-200. PubMed ID: 29523006
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Effects of Calcium, Vitamins D and K co-Supplementation on Markers of Insulin Metabolism and Lipid Profiles in Vitamin D-Deficient Women with Polycystic Ovary Syndrome.
    Karamali M; Ashrafi M; Razavi M; Jamilian M; Akbari M; Asemi Z
    Exp Clin Endocrinol Diabetes; 2017 May; 125(5):316-321. PubMed ID: 28407660
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic response to omega-3 fatty acid supplementation in patients with diabetic nephropathy: A randomized, double-blind, placebo-controlled trial.
    Soleimani A; Taghizadeh M; Bahmani F; Badroj N; Asemi Z
    Clin Nutr; 2017 Feb; 36(1):79-84. PubMed ID: 26611718
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of curcumin on body weight, glycemic control and serum lipids in women with polycystic ovary syndrome: A randomized, double-blind, placebo-controlled trial.
    Jamilian M; Foroozanfard F; Kavossian E; Aghadavod E; Shafabakhsh R; Hoseini A; Asemi Z
    Clin Nutr ESPEN; 2020 Apr; 36():128-133. PubMed ID: 32220355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Effects of Omega-3 Fatty Acids and Vitamin E Co-Supplementation on Indices of Insulin Resistance and Hormonal Parameters in Patients with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial.
    Ebrahimi FA; Samimi M; Foroozanfard F; Jamilian M; Akbari H; Rahmani E; Ahmadi S; Taghizadeh M; Memarzadeh MR; Asemi Z
    Exp Clin Endocrinol Diabetes; 2017 Jun; 125(6):353-359. PubMed ID: 28407657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic response to folate supplementation in overweight women with polycystic ovary syndrome: a randomized double-blind placebo-controlled clinical trial.
    Asemi Z; Karamali M; Esmaillzadeh A
    Mol Nutr Food Res; 2014 Jul; 58(7):1465-73. PubMed ID: 24828019
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.